Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-22-006581

Options or other derivatives

  • Chief Operating Officer acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jeffries Sean Chief Operating Officer 2022-02-01 Grant or award · Stock Option (right to buy) +350,000 350,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…